Etoricoxib is contraindicated in: Patients with known hypersensitivity to Etoricoxib or any component of this product; Patients with active peptic ulceration or gastro-intestinal (GI) bleeding; Patients with severe hepatic dysfunction (Child-Pugh score >9); Patients with estimated creatinine clearance <30 mL/min; Patients who have developed sign of asthma, acute rhinitis, nasal polyps, angioneurotic oedema or urticaria following the administration of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs); Pregnancy and lactation; Children under 16 years of age; Patients with inflammatory bowel disease; Patients with congestive heart failure (NYHA II-IV); Patients with hypertension whose blood pressure has not been adequately controlled; Patients with established ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease (including patients who recently undergone coronary artery bypass graft surgery or angioplasty).
Sign Out
